Schedule
|
17.15 – Tea reception 17.45 – Seats 18.00 – Presenting of Awards 18.30 – Lecture 19.30 – Drinks reception |
The Awards ceremony and lecture are free to attend and open to all, but registration is required in advance – please RSVP to Fran Bertolini (f.bertolini@imperial.ac.uk)
Lecture abstract
|
HIV has become a simple disease to treat for drug developers. In western societies, people with HIV can live or even outlive the general population due to the ongoing infection monitoring. This turnaround has been driven by a wide range of effective drugs, but also a better understanding of how to use them. Improved drug administration could prove valuable in addressing the more severe damage HIV continues to bring to the developing world, where a reliance on a smaller variety of drugs and a lack of education has allowed resistances to develop which spread around the local community. Professor Mark Nelson is a consultant physician at the Chelsea and Westminster Hospital with 25 years’ experience in HIV management. In his inaugural lecture, he will argue that centres of expertise must not only get new drugs out to these committees, but advocates the importance of sharing knowledge regarding education, patient treatment, and clinic management. There is no need for the developing world to repeat mistakes the west have made in their own battle against HIV. |
About the speaker
|
Professor Mark Nelson is a consultant physician at the Chelsea and Westminster Hospital, London. He trained at Jesus College, Cambridge and Westminster Hospital medical school, from where he qualified in 1986. He was appointed Consultant Physician there in 1991 and a senior lecturer at Imperial College Medical School in 1996. Since that time he has built a large HIV practice with a special interest in patient care, co-infection with hepatitis B and C and the clinical utility of new antiretroviral agents. He is presently the director for HIV in patient and day case care. Professor Nelson sits on the Executive Committee of the British HIV Association where he is co-chair of the guidelines committee for opportunistic infections and for hepatitis C. |
He is a member of the Guidelines Committee for Malignancy and HIV transmission. He was chair of the BHIVA hepatitis special interest group and is now the newly elected chair of the BHIVA science and education committee. He is a trustee of several charities associated with HIV including the International Association of Physicians in AIDS care (IAPAC) and St Stephens AIDS Trust, a charity committed to the improvement of life for all those living with HIV where he is head of overseas development and education. He is now devoting most of his charitable time to GREENSHOOTS where he is establishing HIV treatment networks in Burma. He has been awarded a visiting professorship at the Aga Khan Hospital, Nairobi, Kenya and most recently the certificate of merit by the government of Vietnam.